News & Events zu Yesway Inc (YSWY)YSWYYesway Inc

Yesway Q1 Same-Store Sales Up 4.5%

Reports Q1 same-store inside merchandise sales up 4.5% vs. the prior-year period and total inside merchandise sales increased 9.5% year-over-year, with a total inside margin of 36.1%. "We are pleased to report record Q1 results following the successful completion of our public offering," said CEO Thomas Trkla. "Our strong performance reflects the continued execution of our growth strategy and the strength of our differentiated convenience and foodservice platform. During the quarter, we delivered meaningful year-over-year growth across our foodservice, merchandise, and fuel businesses, with fuel sales and margins increasing as we benefited from disciplined operations, strong customer demand, and the continued maturation of our store base. Our momentum has carried into Q2, and we remain confident in the resilience of our business model and the significant opportunity ahead...With our resilient business model and thoughtful capital allocation strategy, we believe Yesway is well-positioned to continue delivering profitable growth and create long-term value for our shareholders. We are grateful for the dedication of our team members and excited about the significant opportunities ahead as we continue to scale our platform and serve the communities in which we operate."

X-energy and Yesway Show Strong Debut Performance

X-energy and Yesway have both made their public debuts last week after pricing. The launches highlighted continued investor appetite across both energy innovation and everyday retail.LATEST IPOS AND DIRECT LISTINGS:X-energyopened on April 24 at $30.11. The developer of advanced small modular nuclear reactors and fuel technology for clean energy generation priced 44.25M shares at $23.00. The deal size was increased to 44.25M shares from 42.86M and priced above the $16.00-$19.00 target range.Elmetopened on April 23 at $18. The company priced 8.6M shares at $14.00 per share. The deal size was increased to 8.6M shares of common stock from 7.7M shares and priced at the high-end of the $12.00-$14.00 range. Elmet is a U.S.-based provider of precision-engineered components and advanced high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries.Yeswayopened on April 22. The company had priced its IPO at $20 per share. Yesway is a U.S.-based convenience store operator that operates primarily under two brands, Yesway and Allsup's.National Healthcare Propertiesopened on April 22 at $11.56. The company priced 38.5M shares of its Class A common stock at $12.00 per share. National Healthcare Properties is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on senior housing and outpatient medical facilities located in the United States.Liberty Defenseopened on April 22. The company priced 3.67M shares at $4.50, the midpoint of its $4.00-$5.00 range. Liberty Defense provides multi-technology security solutions for concealed weapons detection in high volume foot traffic areas and locations requiring enhanced security such as airports, stadiums and schools.PERFORMANCE:Prices as of 11 am ET on Monday, April 27X-energy – up almost 15% at $33.57;Elmet – down about 3% at $16.57;Yesway – fractionally down at $21.64;National Healthcare Properties – fractionally up at $12.89;Liberty Defense – up almost 1% at $4.65.RECENT IPOS TO WATCH:HMH Holdingis already seeing coverage roll out, while KPET Ultra Pacelineis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include Tarsier Pharma, Quantinuum, Cerebras, Boundless Group, and Liftoff.Clickto see upcoming IPO calendar on TipRanks.Tarsier Pharma Ltd.filed for an initial public offering of its ordinary shares and applied to list its ordinary shares on the NYSE American under the symbol "TARX". The prospectus stated: "Tarsier Pharma is developing TRS01 and TRS02, novel product candidates based on dazdotuftide, a new molecule with a new mechanism of action for uveitis and uveitic glaucoma. We are attempting to address a significant, underserved market opportunity and have engaged closely with the FDA on our clinical development strategy, including a Special Protocol Assessment agreement for our planned pivotal trial... Although we are still early in this journey, I believe we have the technology, the team, the discipline, and the persistence required to build an enduring company."Honeywellannounced thatQuantinuum, which is majority owned by Honeywell, confidentially submitted a draft registration statement on Form S-1 to the U.S. SEC on February 17, relating to the proposed initial public offering of Quantinuum's common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.Cerebras Systemsannounced that it has filed a registration statement on Form S-1 with the U.S. SEC relating to a proposed initial public offering of its Class A common stock. The number of shares of Class A common stock to be offered and the price range for the proposed offering have not yet been determined. Cerebras intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol "CBRS." Morgan Stanley, Citigroup, Barclays, and UBS Investment Bank will act as lead book-running managers for the proposed offering. Mizuho and TD Cowen will act as bookrunners. Needham & Company, Craig-Hallum, Wedbush Securities, Rosenblatt, and Academy Securities will act as co-managers.Boundless Groupis offering 4M Class A ordinary shares on a firm commitment basis in an initial public offering. The company expects the initial public offering price of its Class A ordinary shares to be in the range of $4.00 to $5.00 per share.Liftoff Mobileannounced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The total number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.OTHER IPO NEWS:Amesiteannounced that it has filed with the U.S. SEC a request for withdrawal of the company's Registration Statement on Form S-1 originally filed on April 20, as the company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement.Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.